Research.Patient.info
Endometrial Cancer Advanced research hub
2 indexed studies · 0 currently recruiting
- authorisedTherapeutic confirmatory (Phase III)
A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator’s Choice (IC) in Patients With Endometrial Cancer After Platinum-Based Chemotherapy and PD(L)-1 Therapy
This study is testing a new drug, Rinatabart Sesutecan (Rina-S), for people with advanced endometrial cancer. It compares Rina-S to standard treatments to see if it works better at slowing down or stopping the cancer's growth and helping people live longer after previous treatments.
Poland · Denmark · Finland - ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety Using Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients with Recurrent, Metastatic, or Persistent Cervical Carcinoma
Germany · Netherlands · France